Señales en vivo de AVEO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 ene 2023 @ 16:00):

Stats
Volumen de hoy	245 298
Volumen promedio	564 056
Capitalización de mercado	0.00
EPS	$-0.130 ( Q3 \| 2022-11-07 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0560 (0.37%)

AADI -5.88%

ABCL 2.20%

ABCM 0.04%

ABEO -3.08%

ABIO -2.77%

ABOS 0.93%

ABSI 4.42%

ABUS -1.31%

ABVX -2.56%

ACAD -0.64%

ACER -17.95%

ACET -8.84%

ACGN 1.29%

ACHL -2.89%

ACHV 2.59%

ACIU -1.00%

ACLX -0.24%

ACRV -4.29%

ACST -3.58%

ACXP 3.23%

ADAG 7.14%

ADAP -3.97%

ADGI 0.87%

ADIL -3.51%

ADMA -1.54%

ADPT 0.59%

ADTX -3.47%

ADVM 1.01%

ADXN -1.60%

AEON -5.61%

AEZS -2.19%

AFMD -2.62%

AGEN -4.44%

AGIO -2.98%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 7.94%

AKRO -2.43%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -0.92%

ALGS -1.09%

ALKS 1.61%

ALLK -10.17%

ALLO -2.50%

ALLR -3.37%

ALNA 3.16%

ALNY 2.09%

ALPN 0.02%

ALPX 0.00%

ALRN -3.00%

ALT -15.59%

ALVR -1.65%

ALXN 0.00%

ALXO -10.50%

ALZN -1.05%

AMRN -4.13%

AMTI -3.13%

ANAB 1.55%

ANEB 7.20%

ANGN 0.00%

ANIX -4.05%

ANL -0.14%

ANNX 1.53%

ANPC -3.15%

APGE 2.08%

APGN 8.48%

APGNW 30.65%

APLM -6.42%

APLS 0.07%

APLT 0.45%

APM 0.21%

APOP 0.38%

APRE -3.13%

APTO 2.55%

APTX 3.17%

APVO 3.35%

ARAV -13.39%

ARCT -6.81%

ARDS -12.13%

ARDX 1.50%

ARGX -1.26%

ARNA 0.00%

ARPO -0.90%

ARQT -3.23%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.76%

ARWR -2.27%

ASLN -2.23%

ASMB -7.14%

ASND -2.31%

ATAI -3.70%

ATHA 10.05%

ATHE 0.08%

ATHX -33.50%

ATNF 0.99%

ATOS 1.94%

ATRA -6.23%

ATXI 1.94%

ATXS -0.33%

AUPH -1.08%

AURA 4.70%

AUTL -3.45%

AVBP -3.03%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.69%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -2.39%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.77%

BCAB -7.84%

BCDA -1.02%

BCDAW -46.41%

BCEL 0.00%

BCLI -0.18%

BCRX 1.64%

BCTX 12.76%

BCTXW 11.64%

BCYC 0.95%

BDRX -4.42%

BDTX 0.00%

BEAM 2.43%

BFRA -2.91%

BGNE -3.01%

BIOR -5.65%

BIVI 1.72%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.45%

BLTE -1.65%

BLU 0.03%

BLUE -4.28%

BMEA -14.59%

BMRN 0.33%

BNOX 4.44%

BNTC -5.76%

BNTX -2.20%

BOLD -9.71%

BOLT -1.36%

BPMC -2.47%

BPTH -6.67%

BPTS -13.47%

BRNS -0.37%

BRTX -4.72%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.48%

CADL 1.06%

CALA 0.00%

CALC -8.27%

CALT -1.87%

CAPR -0.22%

CARA -12.44%

CARM 6.09%

CASI -1.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.67%

CCCC -1.70%

CCXI 0.00%

CDAK 0.00%

CDIO -4.74%

CDIOW -28.57%

CDMO -1.27%

CDMOP 0.04%

CDT -13.82%

CDTTW -39.60%

CDTX -6.28%

CDXC 9.43%

CDXS 9.66%

CELC -2.79%

CELU -1.00%

CELUW -15.56%

CERC -1.68%

CERE -1.52%

CERO -4.60%

CEROW -20.36%

CFRX -27.95%

CGEM 0.49%

CGEN -3.31%

CGON -2.90%

CGTX -3.41%

CHMA -6.00%

CHRS 5.06%

CINC 0.00%

CING -3.75%

CINGW 34.95%

CKPT -0.96%

CLBS -16.75%

CLDX -0.28%

CLGN -0.60%

CLLS -3.11%

CLNN -2.47%

CLNNW 0.00%

CLRB 7.04%

CLSD -3.20%

CLSN -0.68%

CLVS 0.00%

CMMB -1.96%

CMND 3.23%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 1.12%

CNTB 0.00%

CNTX -9.59%

COCP -2.40%

COEPW 32.45%

COGT -2.64%

CORT 3.98%

COYA -2.60%

CPRX -0.46%

CRBP -1.94%

CRBU -7.95%

CRDF 3.54%

CRGX -2.01%

CRIS -4.34%

CRNX -5.97%

CRSP 1.22%

CRTX 2.63%

CRVO -7.90%

CRVS 0.56%

CSBR -3.50%

CTCX -11.20%

CTIC 0.06%

CTMX 0.00%

CTNM 4.37%

CTXR -7.15%

CUE -4.50%

CVAC -4.94%

CVKD -1.26%

CWBR 2.80%

CYAD -12.96%

CYCC 19.53%

CYCCP 6.99%

CYCN 7.81%

CYT -2.27%

CYTK -2.12%

CYTO 0.91%

DARE -0.30%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 30.97%

DNLI -1.74%

DNTH -2.27%

DOMH -1.06%

DRMA -3.31%

DRMAW -1.25%

DRNA 0.00%

DRTS 2.31%

DRTSW -8.92%

DRUG -0.10%

DSGN -2.42%

DTIL 1.04%

DYAI 9.68%

EARS -1.77%

EDIT -3.22%

EDSA 4.14%

EFTR -3.93%

EFTRW -55.56%

EIGR -9.21%

ELAB -2.41%

ELDN 6.72%

ELEV -2.49%

ELOX 6.15%

ELTX -5.29%

ELVN -1.35%

ELYM 10.04%

ENGN -1.23%

ENGNW -22.50%

ENLV -0.72%

ENOB 1.79%

ENSC 6.53%

ENTA -0.33%

ENTO -4.97%

ENTX 1.60%

ENVB 3.10%

EPIX 2.89%

EPRX -2.87%

EPZM 0.00%

EQ -1.14%

EQRX -2.09%

EQRXW 0.00%

ERAS 5.77%

ERNA -1.11%

ERYP 1.30%

ESLA -1.08%

ESLAW 1.62%

ETNB -7.00%

ETON 2.44%

ETTX 0.00%

EVAX 1.42%

EVGN 2.16%

EVLO 0.00%

EWTX 0.52%

EXAI 0.19%

EXEL 0.54%

EYEG -0.67%

EYEN -3.08%

EYPT -0.85%

FATE -12.37%

FBIO 0.59%

FBIOP 0.87%

FBLG -10.20%

FBRX -0.04%

FDMT -4.50%

FENC -2.90%

FGEN -9.83%

FHTX 5.34%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.72%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -2.31%

GBIO -1.06%

GBT 0.01%

GDTC 2.03%

GERN -1.55%

GHRS -4.10%

GLMD -2.48%

GLPG -1.91%

GLSI 11.18%

GLTO -3.90%

GLUE -2.64%

GLYC -12.60%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.87%

GNPX -3.92%

GNTA 3.94%

GOSS -7.00%

GOVX -8.41%

GOVXW 10.89%

GPCR -5.21%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.78%

GRTX 2.19%

GTHX 2.27%

GUTS 0.69%

GXGXW 41.67%

GYRE -5.65%

HALO -0.76%

HARP 0.09%

HCWB -7.15%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.86%

HOWL 0.00%

HRMY 3.32%

HRTX 9.18%

HSTO 0.00%

HUMA 1.42%

HUMAW -6.25%

IBRX -6.88%

ICCC -0.44%

ICPT 0.21%

ICU 18.87%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.43%

IFRX -1.23%

IGMS -2.05%

IKNA -2.38%

IKT 0.00%

IMAB -0.87%

IMCR -4.15%

IMGN 0.02%

IMGO 0.00%

IMMP 5.32%

IMMX -5.17%

IMNM 4.25%

IMNN -1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.50%

IMTX -1.50%

IMTXW 6.00%

IMUX -9.19%

IMV 0.00%

IMVT -4.51%

INAB -1.80%

INBX -3.11%

INCY -2.14%

INDP 8.72%

INFI -52.38%

INKT 0.00%

INM 0.77%

INMB 1.96%

INO 1.56%

INSM -1.05%

INTS -3.14%

INVA 0.87%

INZY 1.14%

IOBT -7.09%

IONS 1.49%

IOVA -4.02%

IPA 0.50%

IPHA 2.54%

IPSC -3.91%

IRON -2.47%

ISEE 0.38%

ITOS 2.87%

ITRM 1.67%

IVA 6.96%

IVVD 0.00%

JAGX 1.31%

JANX -4.03%

JAZZ -0.85%

JNCE 0.00%

JSPR -1.50%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.96%

KALV -2.08%

KDNY 0.22%

KMPH -0.34%

KNSA -2.32%

KNTE -0.38%

KOD -9.49%

KPRX -4.08%

KPTI -8.71%

KRBP -10.00%

KRON 0.74%

KROS -0.22%

KRRO 0.09%

KRTX 0.03%

KRYS 0.82%

KTRA 9.55%

KTTA -0.65%

KTTAW 82.57%

KURA 0.54%

KYMR -4.04%

KYTX -6.07%

KZIA 4.51%

KZR -3.84%

LABP 0.57%

LBPH 1.57%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.15%

LENZ -3.67%

LEXX 0.77%

LEXXW 23.81%

LGND -1.37%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -9.42%

LIXT -9.81%

LIXTW 45.97%

LJPC -0.32%

LMNL 0.12%

LOGC 0.52%

LPCN -3.68%

LPTX -3.30%

LQDA 0.33%

LRMR -0.21%

LSTA -1.16%

LTRN 6.48%

LUMO 0.67%

LVTX -4.64%

LXEO -13.22%

LXRX -1.18%

LYEL -36.03%

LYRA 3.49%

MACK 0.10%

MBIO -11.26%

MBRX -1.43%

MCRB 0.05%

MDGL -1.67%

MDNA -13.16%

MDWD 4.25%

MDXG -1.77%

MEIP 0.00%

MESO -1.48%

MGNX -5.13%

MGTA -7.74%

MGTX 0.00%

MGX 1.88%

MIRM -0.84%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -6.54%

MLECW 3.08%

MLND -5.36%

MLTX 1.23%

MLYS -8.87%

MNKD -0.95%

MNMD 2.83%

MNOV 0.70%

MNPR -9.09%

MOLN 0.76%

MOR 0.45%

MORF -3.16%

MREO -0.29%

MRKR 1.50%

MRNA -11.01%

MRNS -7.35%

MRSN -3.81%

MRTX -0.17%

MRUS 0.37%

MRVI 1.02%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.95%

MYMD 2.16%

NAMS 0.41%

NAMSW 0.64%

NAUT -1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 10.66%

NCNA -1.45%

NERV -0.32%

NEXI 1.47%

NGM -1.28%

NGNE 2.93%

NKGN 9.24%

NKGNW -20.91%

NKTR 1.40%

NKTX -2.61%

NLSP 7.41%

NLSPW 26.67%

NMRA -1.71%

NMTR -42.97%

NOVN -24.84%

NRBO 13.38%

NRIX -1.63%

NRSN 2.60%

NRSNW 0.00%

NRXP -10.41%

NRXPW 18.33%

NRXS 1.20%

NTBL 2.67%

NTEC -12.45%

NTHI 0.00%

NTLA -4.54%

NTRBW -31.07%

NUVL -1.98%

NVAX -6.36%

NVCT -8.45%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 2.37%

OABIW 2.60%

OBIO 0.15%

OBSV 0.00%

OCEA -3.52%

OCGN 8.47%

OCS 0.25%

OCUL 1.07%

OCUP 0.33%

ODT -4.27%

OKYO 1.72%

OLMA -5.71%

OMER -1.80%

OMGA -2.08%

ONCO 9.93%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.97%

ONTX -0.47%

ONVO 1.00%

OPNT 0.00%

OPT -3.09%

ORGS 1.65%

ORIC -1.63%

ORMP 14.73%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.69%

OVID 1.80%

OYST 0.00%

PALI -0.43%

PASG 0.00%

PBLA -7.50%

PBM -3.26%

PBYI 6.08%

PCSA -0.97%

PCVX 0.74%

PDSB -3.80%

PEPG 0.89%

PGEN -7.19%

PHAR 1.99%

PHAS 0.00%

PHAT -1.06%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.55%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.11%

PLUR 10.43%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT 2.13%

PRAX 6.33%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 1.79%

PRQR -0.60%

PRTA -3.90%

PRTC -2.46%

PRTG 0.09%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.37%

PSTX -4.26%

PTCT -0.37%

PTE -0.82%

PTGX 0.16%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.90%

QLGN -7.17%

QNCX 2.04%

QNRX -1.34%

QSI -28.31%

QSIAW -9.50%

QTTB 4.94%

QURE -1.35%

RAIN -1.63%

RANI 4.01%

RAPT -0.97%

RARE 1.71%

RCKT -10.73%

REGN -0.19%

RENB -2.48%

REPL -1.25%

RETA 0.02%

REUN -0.89%

REVB -7.44%

REVBU 3.46%

REVBW 4.38%

RGLS -4.67%

RGNX -6.57%

RIGL -6.24%

RLAY -7.12%

RLMD 0.00%

RLYB -6.04%

RNA 2.46%

RNAC 2.87%

RNAZ -0.96%

RNXT 0.89%

ROIV -2.40%

ROIVW 4.56%

RPHM -2.48%

RPRX -1.19%

RPTX -1.17%

RUBY 2.70%

RVLP -32.05%

RVMD -1.06%

RVMDW -30.00%

RVNC -0.43%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.61%

RYTM -6.74%

RYZB 0.02%

RZLT 3.36%

SABS -3.41%

SABSW -5.53%

SAGE -0.55%

SANA -3.14%

SAVA -3.78%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.56%

SCPH 12.12%

SCPS 0.00%

SEEL -2.79%

SEER -1.76%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.19%

SGMT -4.83%

SGTX -2.56%

SIOX 22.63%

SLDB -1.72%

SLGL 5.23%

SLN -8.22%

SLNO 1.59%

SLRX 0.40%

SLS -4.27%

SMMT -3.00%

SNDX 1.74%

SNGX 3.02%

SNPX -2.77%

SONN 0.20%

SPPI -0.49%

SPRB -1.64%

SPRC -2.99%

SPRO 0.00%

SRNE 0.00%

SRPT -0.73%

SRRA 0.00%

SRRK -2.85%

SRZN 6.13%

STAB 0.00%

STOK -7.38%

STRO -1.84%

STSA 0.00%

STTK 6.61%

SURF -0.93%

SVRA 1.05%

SWTX -0.49%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.90%

TARS -2.13%

TBPH 0.12%

TCBP 8.77%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT -1.21%

TCRX -1.29%

TECH -1.33%

TENX -0.32%

TERN -8.00%

TFFP -12.18%

TGTX -7.61%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.41%

TNGX -4.21%

TNXP -10.00%

TNYA -4.73%

TPST 4.85%

TRDA -4.54%

TRVI 1.53%

TRVN 2.74%

TSHA -17.24%

TSVT -4.26%

TTNP -6.21%

TVTX 3.64%

TYRA -6.95%

UBX -2.13%

UNCY -4.00%

URGN 4.18%

UTHR -0.03%

VACC 11.36%

VALN -3.15%

VAXX 113.13%

VBIV -0.78%

VBLT -8.77%

VCEL 1.94%

VCNX 5.26%

VCYT -1.01%

VERA -4.29%

VERU 0.54%

VERV -4.02%

VIGL 1.61%

VINC 2.81%

VIR -1.30%

VIRI -4.25%

VIRX -1.75%

VKTX -0.86%

VLON -13.04%

VNDA -2.61%

VOR -7.26%

VRCA 0.14%

VRDN -3.53%

VRNA -2.33%

VRPX -0.48%

VRTX 0.04%

VSTM 4.42%

VTGN -2.11%

VTVT -0.18%

VTYX -2.93%

VXRT -2.09%

VYGR -0.26%

VYNE -7.51%

VYNT 7.78%

WINT -2.72%

WVE -8.28%

XBIO 1.03%

XBIT 1.88%

XCUR 1.26%

XENE -1.16%

XERS 4.76%

XFOR 4.17%

XLO 1.33%

XLRN 0.00%

XNCR 0.41%

XOMA -7.75%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.97%

ZNTL -0.95%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-01-19	Bate Kenneth	Sell	375	Common Stock
2023-01-19	Bate Kenneth	Sell	22 500	Stock Option (Right to Buy)
2023-01-19	Evnin Anthony B	Sell	22 500	Stock Option (Right to Buy)
2023-01-19	Ledell Jebediah	Sell	27 702	Stock Option (Right to Buy)
2023-01-19	Ferraresso Michael	Sell	220 000	Stock Option (Right to Buy)

INSIDER POWER
45.19
Last 96 transactions
Buy: 43 011 518 \| Sell: 9 966 796

Volumen Correlación

Largo: 0.17 (neutral)

Corto: 0.33 (neutral)

Signal:(73.104) Neutral

Aveo Pharmaceuticals Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aveo Pharmaceuticals Inc Correlación - Moneda/Commodity

0.47
( neutral )

0.37
( neutral )

0.50
( weak )

0.32
( neutral )

0.29
( neutral )

-0.69
( moderate negative )

Aveo Pharmaceuticals Inc Finanzas

Annual	2021
Ingresos:	$38.87M
Beneficio Bruto:	$34.14M (87.81 %)
EPS:	$-2.49

FY	2021
Ingresos:	$38.87M
Beneficio Bruto:	$34.14M (87.81 %)
EPS:	$-2.49

FY	2020
Ingresos:	$6.02M
Beneficio Bruto:	$4.77M (79.32 %)
EPS:	$-1.660

FY	2019
Ingresos:	$28.80M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$0.610

Financial Reports:

No articles found.

Aveo Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aveo Pharmaceuticals Inc

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC, HCC, immunologically cold tumors, and CCA. The company has also completed a Phase II clinical trial of tivozanib in combination with Opdivo (nivolumab) for the treatment of RCC. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of squamous cell carcinoma of the head and neck, pancreatic cancer, and acute myeloid leukemia; AV-203, a potent humanized IgG1 monoclonal antibody, which completed Phase I clinical trial for treating human ErbB3; and AV-380, a potent humanized IgG1 inhibitory monoclonal antibody that is in a Phase I clinical trial for the treatment or prevention of cachexia. The company's preclinical stage product includes AV-353 that targets the Notch 3 pathway. AVEO Pharmaceuticals, Inc. has collaboration agreements with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec International GmbH; Kyowa Kirin Co., Ltd.; and AstraZeneca PLC. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.